Press "Enter" to skip to content

Johnson & Johnson quarterly profit jumps 32%

Johnson & Johnson on Wednesday posted a 32% rise in fourth-quarter profit, boosted by demand for its cancer drugs Darzalex and Imbruvica.

Source:: Breaking News

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *